Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal CancerTakashi Kojima, Éric François, Antoine Adenis et al.|Journal of Clinical Oncology|2020Cited by 1.2k
Phase <scp>II</scp> trial of aflibercept with <scp>FOLFIRI</scp> as a second‐line treatment for Japanese patients with metastatic colorectal cancerTadamichi Denda, Takayuki Yoshino, Daisuke Sakai et al.|Cancer Science|2019Cited by 39